A pilot study to determine the occurrence of concomitant diseases and drug intake in patients on antituberculosis therapy

INTRODUCTION: Altered pharmacokinetics of antituberculosis (anti-TB) drugs due to interaction with non-TB medications or concomitant diseases may lead to suboptimal plasma levels of the affected drugs and hence contribute to the emergence of drug resistance in mycobacteria. Yet, few studies have inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhaj, Ratinder, Sharma, Shweta, Sabir, Mohammed, Kokane, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060940/
https://www.ncbi.nlm.nih.gov/pubmed/30090786
http://dx.doi.org/10.4103/jfmpc.jfmpc_103_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060940/
https://www.ncbi.nlm.nih.gov/pubmed/30090786
http://dx.doi.org/10.4103/jfmpc.jfmpc_103_17

Ejemplares similares